The impact of the COVID‑19 pandemic on social determinants of health, mental health, and substance use among key populations affected by sexually transmitted and blood‑borne infections in Canada
Apelian H., Aho J., Wong E., Cox J., Canadian Journal of Public Health, 2024
Including Families in a Response to the Unregulated Toxic Drug Crisis: A Call to Action
Mathias H, Auger S, Schulz P, Hyshka E., Subst Use Misuse.
HIV incidence and factors associated with HIV risk among people who inject drugs engaged with harm-reduction programmes in four provinces in South Africa: a retrospective cohort study
Artenie A., Perry R., Mahaso M., Jankie T., McNaughton A.L., Stone J., Vickerman P., Scheibe A., The Lancet HIV, 2024
Association between adverse childhood experiences and substance use among adolescents in Quebec: a population-based study
Laforest J., Gagnon M., Fallu J.-S., Huynh C., Canadian Journal of Public Health, 2024
Pathways from adolescent screen time to eating related symptoms: a multilevel longitudinal mediation analysis through self‑esteem
Livet A., Boers E., Laroque F., Afzali M.H., McVey G., Conrod P., Psychology & Health, 2024
Recherche participative : perspectives croisées autour des savoirs académiques et expérientiels dans le domaine des addictions
Bertrand K., Knight S., Jauffret‑Roustide M., Santé Publique, 2024
HIV Treatment Optimism Moderates the Relationship between Sexual Risk Behavior and HIV Risk Perception among Urban HIV‑negative Gay, Bisexual, and Other Men who have Sex With Men
Luz P.M., Apelian H., Lambert G., Fourmigue A., Dvorakova M., Grace D., Lachowsky N., Hart T.A., Moore D.M., Skakoon‑Sparling S., Cox J., AIDS and Behavior, 2024
Impact of the COVID‑19 pandemic on hepatitis C virus screening in provincial prisons in Montreal, Quebec, Canada
Kronfli N., Leone F., Dussault C., Miliani G., Gallant E., Potter M., Cox J., Frontiers in Public Health, 2024
Opioid prescribing requirements to minimize unused medications after an emergency department visit for acute pain: a prospective cohort study
Daoust R., Paquet J., Emond M., Iseppon M., Williamson D., Yan J.W., Perry J.J., Huard V., Lavigne G., Lee J., Lessard J., Lang E., Cournoyer A., CMAJ : Canadian Medical Association Journal, 2024
Impact of Depressive Symptom Severity on Buprenorphine/Naloxone and Methadone Outcomes in People With Prescription‑Type Opioid Use Disorder: Results From a Pragmatic Randomized Controlled Trial
Bastien G., Abboud A., McAnulty C., Elkrief L., Ledjiar O., Socias M.E., Le Foll B., Bahji A., Brissette S., Marsan S., Jutras‑Aswad D., Journal of Dual Diagnosis, 2024
